domingo, 21 de septiembre de 2014

Cadila Healthcare

Cadila Healthcare (BSE: 532321) is an Indian pharmaceutical company headquartered at Ahmedabad in Gujarat state of western India. The company is the fifth largest pharmaceutical company in India, with INR 29.78 Bn in turnover in 2011. It is a significant manufacturer of generic drugs.
History
Cadila Laboratories was founded in 1952 by Ramanbhai Patel(1952–2001), formerly a lecturer in the L.M. College of Pharmacy, and his business partner Shri Indravadan Modi. The company evolved over the next four decades into one of India's established pharmaceutical companies.
In 1995 the Patel and Modi families split, with the Modi family's share being moved into a new company called Cadila Pharmaceuticals Ltd. and Cadila Healthcare became the Patel family's holding company. Cadila Healthcare did its IPO on the Bombay Stock Exchange in 2000. Its stock code on the Bombay exchange is 532321.
In 2001 the company acquired another Indian pharmaceutical company...

No hay comentarios:

Publicar un comentario